BR
Schedule 13G filing
BlackRock, Inc. disclosed a 6.6% stake in KYMR
BlackRock, Inc. reported owning 6.6% of Kymera Therapeutics, Inc. (KYMR) (5,450,286 shares) in a Schedule 13G filed Oct 27, 2026.
A 13G is a passive stake: the holder does not plan to push for changes.
- Disclosed
- Oct 27, 2026
- Source
- Schedule 13G
More KYMR insider and Congress trades
From a public Schedule 13G, linked above. Not investment advice, and not a recommendation to buy or sell.